Drug intelligence / Profile preview

JCQ-ORTHO

Development stage: Unknown
Lead developer: Jointcare Pharmaceuticals
Modality: Small Molecules
Administration: Oral

Overview

JCQ-ORTHO is a branded nutritional supplement and combination product developed by Jointcare Pharmaceuticals, an Indian pharmaceutical company specializing in musculoskeletal health. It is part of the JCQ product line, which typically features formulations containing antioxidants and nutritional supplements such as Co-Enzyme Q10 and L-Carnitine. JCQ-ORTHO is specifically marketed for the management of orthopaedic and joint conditions, aiming to support joint health and provide relief from musculoskeletal pain. It is administered orally, usually in tablet form, and is currently approved and commercially available in the Indian market as part of a broader portfolio of joint care and pain relief products.

Brand names: JCQ-ORTHO
Other names: JCQ ORTHO

Beyond the preview

Go deeper on JCQ-ORTHO.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on JCQ-ORTHO.

Explore the full profile